CN115337368A - 一种治疗多种肛肠病的药物及其制备方法 - Google Patents
一种治疗多种肛肠病的药物及其制备方法 Download PDFInfo
- Publication number
- CN115337368A CN115337368A CN202110538260.4A CN202110538260A CN115337368A CN 115337368 A CN115337368 A CN 115337368A CN 202110538260 A CN202110538260 A CN 202110538260A CN 115337368 A CN115337368 A CN 115337368A
- Authority
- CN
- China
- Prior art keywords
- medicine
- medicines
- root
- artificial
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 229940079593 drug Drugs 0.000 title claims abstract description 31
- 208000015815 Rectal disease Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 41
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000011787 zinc oxide Substances 0.000 claims abstract description 30
- 235000014692 zinc oxide Nutrition 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 24
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 17
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940099259 vaseline Drugs 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 15
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims abstract description 15
- 206010004542 Bezoar Diseases 0.000 claims abstract description 15
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 15
- 244000124209 Crocus sativus Species 0.000 claims abstract description 15
- 229940116229 borneol Drugs 0.000 claims abstract description 15
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940105847 calamine Drugs 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910052864 hemimorphite Inorganic materials 0.000 claims abstract description 15
- 239000004248 saffron Substances 0.000 claims abstract description 15
- 235000013974 saffron Nutrition 0.000 claims abstract description 15
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 9
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 9
- 239000008308 lipophilic cream Substances 0.000 claims abstract description 5
- 239000000022 bacteriostatic agent Substances 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 239000011259 mixed solution Substances 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 241000218202 Coptis Species 0.000 claims description 11
- 229910001220 stainless steel Inorganic materials 0.000 claims description 10
- 239000010935 stainless steel Substances 0.000 claims description 10
- 241000972673 Phellodendron amurense Species 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 230000003068 static effect Effects 0.000 claims description 9
- 241000246044 Sophora flavescens Species 0.000 claims description 8
- 241001671204 Stemona Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 241000219784 Sophora Species 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 241000037740 Coptis chinensis Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241000218691 Cupressaceae Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 201000004624 Dermatitis Diseases 0.000 abstract description 7
- 208000010668 atopic eczema Diseases 0.000 abstract description 6
- 208000014617 hemorrhoid Diseases 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 241000972672 Phellodendron Species 0.000 abstract description 4
- 239000006210 lotion Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 210000000436 anus Anatomy 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000000499 gel Substances 0.000 abstract description 3
- 206010048946 Anal abscess Diseases 0.000 abstract description 2
- 206010002153 Anal fissure Diseases 0.000 abstract description 2
- 208000016583 Anus disease Diseases 0.000 abstract description 2
- 208000009531 Fissure in Ano Diseases 0.000 abstract description 2
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 206010058046 Post procedural complication Diseases 0.000 abstract 1
- 208000035965 Postoperative Complications Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000011265 semifinished product Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 15
- 208000003251 Pruritus Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- -1 panaxatriol saponin Chemical class 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000417534 Stemona sessilifolia Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗多种肛肠病的药物及其制备方法,它属于治疗多种肛肠病技术领域,它的组成分别为:人工麝香、人工牛黄、煅炉甘石、珍珠、冰片、氧化锌、藏红花、黄连、黄柏、苦参、百部、三七、凡士林、甘油、抑菌剂,醋酸氯已定和部分辅助料。把上述中药通过精选,部分药经过清洗、粉碎、煎煮等一系列工艺,在配制过程中一部分制成油相,一部分制成水相,把这两种半成品溶在一起就制成油包水的乳膏剂成品,用此配方还可以制成凝胶剂、散剂、外洗剂等,但都对治疗、痔疮、肛裂、肛周脓肿、肛门术后并发病、肛周湿疹和炎性外痔等多种疾病都有很好的治疗效果。
Description
技术领域:
本发明涉及一种治疗肛肠病的药物及其制备方法。这种特殊配方能够对多种肛肠疾病都有很好疗效。
背景技术
近年来我国的肛肠疾病发病率一直很高,这都是由于饮食及风、湿、燥、热、瘀为主要原因造成的,肛肠病给患者的生活和工作带来了极大的影响。本发明所提供的这个配方是根据中医理论结合自己多年临床经验,理论实践相结合的一种科学配方,再加上特殊制备工艺,提高了产品的疗效。用这个配方可制成乳膏剂、凝胶剂、散剂、外洗剂等,针对不同的肛肠病,选择适宜剂型,肛门湿疹等皮肤病用散剂、外洗剂。直肠有病用凝胶剂直肠注入。痔瘘外用敷抹药用膏剂,以便发挥其更好的治疗作用。
本发明的配方患处给药渗透力强,肛直肠里外兼治,直接作用于病灶,这样避免了口服药对肝肾体循环吸收的毒副作用。此方能收湿敛疮,祛腐生肌,抑菌止痒,清热解毒,消肿止痛,活血化瘀,效果显著。此方精选的药物是:人工麝香、人工牛黄、煅炉甘石、珍珠、冰片、氧化锌、藏红花、黄连、黄柏、苦参、百部、三七、醋酸氯己定;在制备乳膏剂过程中加辅料凡士林、甘油。
①本发明所精选的药物人工麝香,能开窍辟秽、活血散结,主治热病神昏、中风痰厥、惊痛、心腹暴痛、跌打疮疡、有消肿止痛、抗菌作用。
②本发明所精选的药物人工牛黄,味微苦,而后甜,性凉归肝心经可用于清热解毒,定惊安神,具有抗炎、抗病原微生物,抗氧化及抑制肿瘤生长的作用,外用对于创伤肿痛,有很好作用。
③本发明所精选的药物藏红花,性味甘平,能养血、补血具有降低血液粘稠度,扩张毛细血管,加快血流速度,舒经活络,促进血液循环,从而增强细胞免疫力,强身健体,延缓衰老的作用。
④本发明所精选的药物珍珠、味咸、甘寒、无毒,能镇心点目,镇静安神,解毒生肌,珍珠粉当中含有非常丰富的氨基酸,可有效提高人的免疫力,增强体质。
⑤本发明所精选的药物冰片味辛、苦、性寒,有开窍醒神,清热止痛的功效,对于喉咙肿痛、口腔溃疡、疮毒肿痛有很好作用。
⑥本发明所精选的药物煅炉甘石,通常用于皮肤用药,具有杀菌、收敛、消炎、止痒、保护伤口的作用,并能抑制局部葡萄球菌的生长,对于皮肤瘙痒、荨麻疹、亚急性湿疹有很好作用。
⑦本发明所精选的药物氧化锌,对于皮炎、湿疹、接触性皮炎都有很好的治疗作用。
⑧本发明所精选的药物三七,性微苦、味甘、归肝经、胃经。有化瘀止血、活血定痛的作用,活血化瘀功效明显,三七中含有人参三醇皂甙成份,能够兴奋大脑中枢,促进脑部血液循环,有很好的抗脑部疲劳作用。
⑨本发明所精选的药物黄连,味苦性寒,能清热燥湿,泻火解毒,黄连还可以有效抑制细菌,保护胃黏膜,同时具有抗炎镇痛作用。
⑩本发明所精选的药物黄柏,味苦、性寒、归肾经、膀胱经。具有清热燥湿、泻火除疮、解毒疗疮等功效,善于清泻肾脏虚火,可用于治疗阴虚火旺、疮疡肿毒,皮肤湿疹瘙痒不适等症。
(12)本发明所精选的药物百部,性味甘平,入肺经,其可以润肺止咳,用于肺阴不足或者肺津受伤引起的咳嗽,另外对于皮肤瘙痒、皮肤病变局部可以起到杀虫、散风、止痒作用。
(13)本发明所精选的药物凡士林,无刺激性,不易造成人体敏感,涂抹在皮肤上,使水分不易蒸发、散失,并且能阻挡来自空气中的细菌。使其成为油相膏制作基质。
(14)本发明所精选的药物甘油,无色,有治疗便秘,治疗皮肤皲裂的功效。使其成为水相膏基质。
(15)本发明所精选的原料,醋酸氯己定,本品具有消炎作用,对于各种皮肤及黏膜的消毒、创面感染都有很好的使用及防腐保质作用。
本发明所精选的配方,在制备乳膏剂以外的剂型产品中,如散剂、凝胶剂中不需要加甘油和凡士林。
本发明的科学配方精选道地名贵中草药和矿物药,对于多种肛肠疾病都有独特疗效,并且在制备工艺上也比较特殊,把这几味中药经过多道工序一系列工艺制成适宜剂型,才能得到疗效显著的成品,因此开发这种产品是很有必要的。
发明内容:
本发明的目的是提供一种治疗肛肠病的药物及其制备方法,这个配方制成膏剂等剂型涂抹在病灶上对于肛肠的多种疾病都有很好的治疗作用。
本发明解决其技术问题所采用的技术方案是:一种治疗肛肠病的药物及其制备方法的第一组药物组成分别为:人工麝香0.3~1g,人工牛黄1.5~3.5g,珍珠1~3g,冰片0.3~1g,煅炉甘石6~20g,氧化锌2~7g,第二组药物组成分别为:藏红花15-30g,黄连15-50g,黄柏 50~100g,苦参50~100g,百部50~100g,三七30~90g。
本制备乳膏剂过程中还要逐步加入凡士林、甘油、醋酸氯己定和部分其它辅助料。余量为净化水。(10日之用量)
优选比例为,第一组药物组成分别为:人工麝香0.6g,人工牛黄 2.5g,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g,第二组药物组成分别为:藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g;辅料为凡士林ng,甘油ng,醋酸氯己定ng和其它辅助料。余量为净化水。(10日之用量)
生产工艺为:
①取精选的第一组药物配方比例人工麝香0.3~1g,人工牛黄 1.5~3.5g,珍珠1~3g,冰片0.3~1g,煅炉甘石6~20g,氧化锌2~7g备用。
②把上述精选的原料进行粉碎,过290-300目筛。备用。
③取凡士林ng,用不锈钢容器加热50~80℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液备用。
④取精选第二组药物配方比例,藏红花15-30g,黄连15-50g,黄柏50~100g,苦参50~100g,百部50~100g,三七30~90g,一并倒入纯净水中进行清洗干净后,再加兑总量8~10倍的水,并加热慢火煎煮 3~5小时,冷却后过滤浓缩得到活性物的混合静提液,加入甘油ng,混合均匀配制成水相混合溶液备用。
⑤把在④中制成水相活性混合溶液,加入到③的油相浓液中,再加入醋酸氯己定ng和微量辅料,同时加温至85℃,并搅拌均匀,使其乳化成乳霜状膏体,即成成品油包水的乳膏剂。
优选:一种治疗肛肠病的药物及其制备方法,其步骤如下:
①取精选的第一组药物按配方比例:人工麝香0.6g,人工牛黄2.5g,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g,备用。(10 日之用量)
②把精选的上述药物混合在一起粉碎过300目筛,备用。
③取凡士林ng,用不锈钢容器加热50~80℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液备用。
④把精选的配方第二组药物按比例取藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g,一并倒入纯净水中进行清洗干净后,再加兑总量8~10倍的水,并加热慢火煎煮5小时,冷却后过滤浓缩得到活性物的混合静提液,再加入甘油ng,混合均匀配制成水相混合液备用。
⑤把在④中制成水相活性混合溶液,加入到③的油相浓液中,再加入醋酸氯己定ng和微量辅料,同时加温至85℃,并搅拌均匀,使其乳化成乳霜状膏体,即成成品油包水的乳膏剂。
本发明采用精选道地名贵中草药和矿物药及醋酸氯己定,加入辅料,经过加工熬制,分别制成油状物和水状活性混合溶液,再经过混合乳化就制成乳霜状膏剂,这样用起来不但方便,而且对于治疗多种肛肠疾病都有显著的疗效。
具体实施方式:
本发明具体实施方式的药物组成是,第一组药物组成分别为:人工麝香0.3~1g,人工牛黄1.5~3.5g,珍珠1~3g,冰片0.3~1g,煅炉甘石6~20g,氧化锌2~7g,第二组药物组成分别为:藏红花15-30g,黄连15-50g,黄柏50~100g,苦参50~100g,百部50~100g,三七30~90g。凡士林ng、甘油ng、醋酸氯己定ng,部分其它辅助料。余量为净化水。 (10日之用量)。优选比例为,第一组药物组成分别为:人工麝香0.6g,人工牛黄2.5g,,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g;第二组药物组成分别为:藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g,凡士林ng,甘油ng,醋酸氯己定ng和其它辅助料。余量为净化水。(10日之用量)
生产工艺为:
①取精选的药物比例为,第一组药物组成分别为:人工麝香 0.3~1g,人工牛黄1.5~3.5g,珍珠1~3g,冰片0.3~1g,煅炉甘石6~20g,氧化锌2~7g备用。
②把上述精选的原料进行混合粉碎,过290-300目筛。备用。
③取凡士林ng,用不锈钢容器加热50~80℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液备用。
④取精选配方比例为,第二组药物组成分别为:藏红花15-30g,黄连15-50g,黄柏50~100g,苦参50~100g,百部50~100g,三七30~90g,一并倒入纯净水中进行清洗干净后,再加兑总量8~10 倍的水,并加热慢火煎煮3~5小时,冷却后过滤得到活性混合静提液,再加入甘油ng,混合均匀配制成水相混合液备用。
⑤把在④中制成水状活性混合溶液,加入到③的油状浓液中再加入醋酸氯己定ng和微量辅料,同时加温至85℃,并搅拌均匀,使其乳化成乳霜状膏体,即成成品油包水的乳膏剂。
优选:一种治疗肛肠病的药物及其制备方法,其步骤如下:
①取精选的药物比例为,第一组药物组成分别为:人工麝香 0.6g,人工牛黄2.5g,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g,醋酸氯己定ng和其它辅助料。余量为净化水。(10日之用量)
②把精选的上述药物混合在一起粉碎过300目筛,备用。
③取凡士林ng,用不锈钢容器加热50~80℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液备用。
④把精选配方药物比例为,第二组药物组成分别为:取藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g,一并倒入纯净水中进行清洗干净后,再加兑总量10倍的水进行慢火煮5小时,冷却后过滤得到活性混合静提液,在这溶液中加入ng甘油并搅拌均匀,制成水相活性混合溶液备用。
⑤把在④中制成水相活性混合溶液,加入到③的油相状浓液中再加入醋酸氯己定ng和微量辅料,同时加温至85℃,并搅拌均匀,使其乳化成乳霜状膏体,即制成油包水的乳膏剂成品。
本发明精选道地名贵中草药和矿物药经过优选配方和制成适宜剂型,进一步加强了此配方的效力,作用更持久、疗效更好,对于痔疮、肛裂、肛周脓肿、肛周湿疹、肛门术后炎性和并发症都具有清热解毒、消肿止痛、祛风燥湿、抑菌止痒的疗效,这种药物可直达病灶,直接杀菌没有副作用,使用非常方便。这种外用肛肠药物直达患处给药,比口服药更有效果,且避免体内吸收和代谢的副作用,治疗痔瘘等肛肠病有显著疗效。需要注意的是,儿童和孕妇不可以使用,月经期间暂停用药,在使用时也忌食:辛、辣和酒。
显然本发明上述的实施例是为了清楚说明本发明举例,但本发明的保护范围并不局限于此乳膏剂,还可以用此配方制成凝胶剂、散剂、外洗剂,本发明可以有多种剂型用法变形和更改,凡在本发明的构思与原则之内所作的任何修改、改进和等同替换都应包含在本发明的保护范围之内。
Claims (4)
1.一种治疗多种肛肠病的药物及其制备方法,其特证在于由以下多种药物制成:第一组药物组成分别为:人工麝香0.3-1g,人工牛黄1.5-3.5g,珍珠1-3g,冰片0.3-1g,煅炉甘石6-20g,氧化锌2-7g。第二组药物组成分别为:藏红花15-30g,黄连15-50g,黄柏50-100g,苦参50-100g,百部50-100g,三七30-90g。凡士林ng,甘油ng,抑菌剂ng,醋酸氯己定ng和其它微量辅助料。余量为净化水。(10日之用量)。
2.按照权利要求1所述的一种治疗多种肛肠病的药物及其制备方法,其特征在于第一组药由以下药物原料组成,人工麝香0.6g,人工牛黄2.5g,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g。第二组药物组成分别为:藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g,凡士林ng,甘油ng,抑菌剂ng,醋酸氯己定ng和其它微量辅助料。余量为净化水。(10日之用量)。
3.一种如权利要求1所述的治疗多种肛肠病的药物及其制备方法,其特征在于步骤如下:
生产工艺为:
①取精选的第一组药物人工麝香0.3-1g,人工牛黄1.5-3.5g,珍珠1-3g,冰片0.3-1g,煅炉甘石6-20g,氧化锌2-7g备用。
②把精选的上述原料进行混合粉碎,过250-300目筛。备用。
③取凡士林ng,用不锈钢容器加热50-80℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液。备用。
④把精选的第三组药物配方比例藏红花15-30g,黄连15-50g,黄柏50-100g,苦参50-100g,百部50-100g,三七30-90g,一并倒入纯净水中进行清洗干净后,再加入总量8-10倍的水,并加热慢火煎煮3-5小时,冷却后过滤得到活性混合静提溶液,在静提液中加入n克甘油,搅拌均匀,制成水相活性混合溶液。备用
⑤把在④中制成水状活性混合溶液,加入到③的油状浓液中再加入抑菌剂ng,醋酸氯己定ng微量辅料,同时加温至85℃,并搅拌均匀,使其乳化成乳霜状膏体,即成成品油包水的乳膏剂。
4.一种如权利要求2所述的治疗多种肛肠病的药物及其制备方法,其特征在于步骤如下:
①取精选的第一组药物人工麝香0.6g,人工牛黄2.5g,珍珠2g,冰片0.6g,煅炉甘石10g,氧化锌5g备用。
②把精选的上述原料进行混合粉碎,过300目筛。备用。
③取凡士林ng,用不锈钢容器加热100℃时,把上述搅拌均匀的药物细粉一并倒入再搅拌均匀,配制成油相浓缩液。备用。
④把精选的第三组药物配方比例藏红花16g,黄连30g,黄柏80g,苦参80g,百部60g,三七50g,一并倒入纯净水中进行清洗干净后,再加入总量10倍的水,并加热慢火煎煮5小时,冷却后过滤得到活性混合静提溶液,在静提液中加入n克甘油,搅拌均匀,制成水相活性混合溶液。备用
⑤把在④中制成水状活性混合溶液,加入到③的油状浓液中再加入抑菌剂ng,醋酸氯己定ng微量辅料,同时加温至100℃,并搅拌均匀,使其乳化成乳霜状膏体,即成成品油包水的乳膏剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110538260.4A CN115337368A (zh) | 2021-05-12 | 2021-05-12 | 一种治疗多种肛肠病的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110538260.4A CN115337368A (zh) | 2021-05-12 | 2021-05-12 | 一种治疗多种肛肠病的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115337368A true CN115337368A (zh) | 2022-11-15 |
Family
ID=83947181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110538260.4A Withdrawn CN115337368A (zh) | 2021-05-12 | 2021-05-12 | 一种治疗多种肛肠病的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115337368A (zh) |
-
2021
- 2021-05-12 CN CN202110538260.4A patent/CN115337368A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772591B (zh) | 一种治疗鼻炎的中空、通气、双层中药栓剂及其制作方法 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN101032593A (zh) | 一种治疗痤疮的中药制剂 | |
CN104524125A (zh) | 一种治疗湿疹的中药乳膏及其制备方法 | |
CN105999105A (zh) | 一种治疗褥疮和糖尿病溃烂的中药组合物及其制备方法 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN105079420A (zh) | 一种用于创面的麻醉膏剂及其制备方法 | |
CN104958581A (zh) | 一种用于治疗毛囊炎的中药制剂及制备方法 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN101554449B (zh) | 一种治疗外伤的中药 | |
CN110384785B (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 | |
CN115337368A (zh) | 一种治疗多种肛肠病的药物及其制备方法 | |
CN113663023A (zh) | 一种用于治疗高血压的灵芝组合物及其制备方法 | |
CN105031380A (zh) | 一种用于孕妇口腔局部麻醉的药物及其制备方法 | |
CN107617081B (zh) | 一种治疗脱发的中药组合物及其制剂与制备方法 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
CN108159276A (zh) | 一种熏蒸液及其制备方法和使用方法 | |
CN107335034A (zh) | 一种治疗白癜风的外用中药组合物及其应用 | |
CN106822674B (zh) | 治疗甲状腺功能亢进的药物组合物,含其制剂及其制备方法与应用 | |
CN105106590A (zh) | 一种用于治疗过敏性鼻炎的药物 | |
CN111671804A (zh) | 中药秘方治疗痔疮外敷药剂 | |
CN116019893A (zh) | 一种中药组合痔疮膏及制备方法 | |
CN112043744A (zh) | 一种用于治疗鼻炎、鼻窦炎的外用药 | |
CN103933359A (zh) | 用于祛除瘢痕疙瘩的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20221115 |
|
WW01 | Invention patent application withdrawn after publication |